Target intelligence / Profile preview

Suppressor of T cell signaling 1 phosphatase (Sts-1)

Target
Sts-1
Molecular classification
Enzyme, Phosphatase, Histidine phosphatase superfamily, Phosphoglycerate mutase (PGM)-like enzyme
01

Overview

Suppressor of T cell signaling 1 phosphatase (Sts-1, also known as UBASH3B or TULA-2) is a member of the histidine phosphatase superfamily that functions as a negative regulator of signaling pathways downstream of tyrosine kinase receptors, most notably the TCR and BCR in immune cells[1][3][7]. Sts-1 contains a C-terminal phosphoglycerate mutase (PGM)–like domain responsible for its intrinsic tyrosine phosphatase activity, as well as ubiquitin (UBA) and SH3 domains[7]. It dephosphorylates proteins such as Zap-70, SYK, EGFR, PDGFR, and Bcr-Abl, modulating immune and cell growth pathways[1][7]. Its inactivation has been linked to increased resistance to certain infections, such as systemic candidiasis, making it a potential therapeutic target for immune modulation and anti-infective strategies[5][8]. Selective small-molecule inhibitors have been identified, including PHPS1 and experimental tetracycline and azo dye derivatives, supporting druggability and experimental modulation of Sts-1 function[2][4][5].

Other names
UBASH3BTULA-2TULA2suppressor of T-cell receptor signaling-1suppressor of T-cell signaling 1
02

Mechanism of action

Competitive inhibition of the phosphatase active site; Negative regulation of key tyrosine kinases (e.g., dephosphorylation of Zap-70, SYK, EGFR, PDGFR, Bcr-Abl)

03

Biological functions

Negative regulation of tyrosine kinase signalingNegative regulation of T cell receptor (TCR) signalingRegulation of immune responseRegulation of B cell receptor (BCR) signalingCell signaling
04

Disease associations

CancerInfection (notably resistance to fungal pathogens when inactivated)Immune system disordersInflammation
05

Safety considerations

Potential immunosuppression due to inhibition of negative immune regulators, possibly leading to exaggerated immune responses or autoimmunityUnderdeveloped safety data for Sts-1-specific small molecule inhibitors
06

Interacting drugs

PHPS1 (a SHP-1 inhibitor shown to potently inhibit Sts-1 in vitro)

1 more in the full profile.

07

Biomarkers

Phosphorylation status of Zap-70 as a functional readout of Sts-1 activityPotential use in infection and immune-related disease monitoring

Beyond the preview

Go deeper on Suppressor of T cell signaling 1 phosphatase (Sts-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suppressor of T cell signaling 1 phosphatase (Sts-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call